Enhanced external counterpulsation in patients with refractory angina pectoris: a pilot study with six months follow-up regarding physical capacity and health-related quality of life

Abstract

Background:

Refractory angina pectoris (AP) is a persistent, painful condition characterized by angina caused by coronary insufficiency in the presence of coronary artery disease. It has been emphasized that there are possible underlying neuropathophysiological mechanisms for refractory AP but chronic ischemia is still considered to be the main problem. These patients suffer from severe AP and cannot be controlled by a combination of pharmacological therapies, angioplasty or coronary bypass surgery. AP has a negative impact on quality of life and daily life. Enhanced external counterpulsation (EECP) is a therapeutic option for these patients.

Aims:

The aim of this study was to evaluate EECP after six months regarding physical capacity and health-related quality of life (HRQoL) in patients with refractory AP.

Methods:

This was a study with single case research experimental design involving 34 patients treated with EECP. Six minute walk test (6MWT), functional class with Canadian Cardiological Society (CCS) classification and self-reported HRQoL questionnaires as Short Form 36 (SF-36) were collected at baseline and after treatment. CCS class and SF-36 were repeated at six months follow-up.

Results:

Patients enhanced walk distance on average by 29 m after EECP (p<0.01). CCS class also improved (p<0.001) and persisted at six months follow-up (p<0.001). HRQoL improved significantly and the effects were maintained at follow-up after the treatment.

Conclusion:

Patients with refractory AP receive beneficial effects from EECP both in physical capacity and HRQoL. As other treatment options for this patient group are scarce, EECP should be offered to improve physical health and HRQoL in these patients.

Keywords

Refractory angina pectoris enhanced external counterpulsation physical capacity health-related quality of life

Get full access to this article

View all access options for this article.

References

Mannheimer

Camici

Chester

. The problem of chronic refractory angina – Report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J 2002; 23: 355–370.

Fox

Alonso

Ardissino

. Guidelines on the management of stable angina pectoris: executive summary The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27: 1341–1381.

McGillon

L’Allier

Arthur

. Recommendations for advancing the care of Canadians living with refractory angina pectoris: A Canadian Cardiovascular Society position statement. Can J Cardiol 2009: 25: 399–401.

Andréll

Ekre

Grip

. Fatality, morbidity and quality of life in patients with refractory angina pectoris. Int J Cardiol 2009; 147: 377–382.

Gibbons

Chatterjee

Daley

. ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina: Executive Summary and Recommendation – A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation 1999; 99: 2829–2848.

Kones

. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization. Vasc Health Risk Manag 2010; 6: 749–774.

Kirwan

B-A

Lubsen

Poole-Wilson

. Treatment of angina pectoris: Associations with symptom severity. Int J Cardiol 2005; 98: 99–306.

Manchanda

Aggarwal

. Management of refractory angina pectoris. Cardiol J 2011; 18: 343–351.

Soran

. Treatment options for refractory angina pectoris: enhanced external counterpulsation therapy. Curr Treat Options Cardiovasc Med 2009; 11: 54–60.

10.

Stanik-Hutt

. Management options for angina refractory to maximal medical and surgical interventions. AACN Clin Issues 2005; 16: 320–332.

11.

Brosche

Middleton

Boogaard

. Enhanced external counterpulsation. Dimen Crit Care Nurs 2004; 23: 208–214.

12.

Manchanda

Soran

. Enhanced external counterpulsation and future directions. State-of-the-art paper. J Am Coll Cardiol 2007; 50: 1523–1531.

13.

Kim

Kini

Sharma

. Refractory angina pectoris. mechanism and therapeutic options. J Am Coll Cardiol 2002; 39: 923–934.

14.

Buschmann

Utz

Pagonas

. Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art. Net.-2 Trial). Eur J Clin Investig 2009; 39: 866–875.

15.

Gloekler

Meier

De Marchi

. Coronary collateral growth by external counterpulsation: A randomised controlled trial. Heart 2010; 96: 202–207.

16.

Masuda

Nohara

Hirai

. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina. Eur Heart J 2001; 22: 1451–1458.

17.

Tartaglia

Stenerson

Charney

. Exercise capability and myocardinal perfusion in chronic angina patients treated with enhanced external counterpulsation. Clin Cardiol 2003; 26: 287–290.

18.

Arora

Chou

Jain

. The multicenter study of enhanced external counterpulsation (MUST-EECP): Effect of EECP on exercise-induced myocardinal ischemia and anginal episodes. J Am Coll Cardiol 1999; 33: 1833–1840.

19.

Bondesson

Pettersson

Erdling

. Comparison of patients undergoing enhanced external counterpulsation and spinal cord stimulation for refractory angina pectoris. Coron Artery Dis 2008; 19: 627–634.

20.

Lawson

Hui

JCK

Kennard

. Two-years outcomes in patients with mild refractory angina treated with enhanced external counterpulsation. Clin Cardiol 2006; 29: 69–73.

21.

Gowda

Khan

Punukollu

. Treatment of refractory angina pectoris. Int J Cardiol 2004; 101: 1–7.

22.

Thompson

Buchner

Piña

. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. A statement From the Council on Clinical Cardiology (Subcommitee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Actvity, and Metabolism (Subcommitee on Physical Activity). Circulation 2003; 107: 3109–3116.

23.

Graham

Atar

Borch-Johnsen

. European Guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Others Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14: E1–E40.

24.

Sullivan

Karlsson

Taft

. SF-36 Hälsoenkät: Svenska Manual och Tolkningsguide (Swedish manual and interpretation guide). 2nd ed. Göteborg: Sahlgrenska Universitetssjukhus, Sektionen för vårdforskning, 2002.

25.

Stewart

. Refractory to medical treatment but not to nursing care: can we do more for patients with chronic angina pectoris? Eur J Cardiovasc Nurs 2003; 2: 169–170.

26.

Gravely-Witte

De Gucht

Heiser

. The impact of angina and cardiac history on health related quality of life and depression in coronary heart disease patients. Chronic Illn 2007; 3: 66–76.

27.

Marquis

Fayol

Joire

J.E

. Clinical validation of a quality of life questionnaire in angina pectoris patients. Eur Heart J 1995; 16: 1554–1560.

28.

American Thoracic Society (ATS). ATS statement: Guidelines for Six-Minute Walk Test. Am J Respir Crit Care Med 2002; 166: 111–117.

29.

Hagströmer

Hassmén

. Bedöma och styra fysisk aktivitet (in Swedish). In: Ståhle

, eds. Physical activity in the prevention and treatment of disease. Stockholm: Professional Societies for Physical Activity YFA, The Swedish National Institute of Public Health, 2008, pp.93–111.

30.

Sullivan

Karlsson

Ware

Jr.

The Swedish SF-36 Health Survey – I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general population in Sweden. Soc Sci Med 1995; 41: 1349–1358.

31.

Erdling

Bondesson

Pettersson

. Enhanced external counter pulsation in treatment of refractory angina pectoris: two year outcome and baseline factors associated with treatment failure. BMC Cardiovasc Disord 2008; 8: 1–7.

32.

Loh

Cleland

Louis

. Enhanced external counterpulsation in the treatment of chronic refractory angina: A long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry. Clin Cardiol 2008; 31: 159–164.

33.

Bonetti

Holmes

Lerman

. Enhanced external counterpulsation for ischemic heart disease. What’s behind the curtain? J Am Coll Cardiol 2003; 41: 1918–1925.

34.

Shechter

Matetzky

Feinberg

. External counterpulsation therapy improves endothelial function in patient with refractory angina pectoris. J Am Coll Cardiol 2003; 42: 2090–2095.

35.

Kumar

Aronow

Vadnerkar

. Effect of enhanced external counterpulsation on clinical symptoms, quality of life, 6-minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow up in 47 patients with chronic refractory angina pectoris. Am J Therapeut 2009; 16: 116–118.

36.

Nigam

Tardif

J-C

. The place of exercise in the patient with chronic stable angina. Heart Metab 2008; 38: 34–37.

37.

Sullivan

Tunsäter

. Hälsorelaterad livskvalitet informativt effektmått i kliniska studier (in Swedish). Health-related quality of life informative endpoints in clinical trials. Läkartidningen 2001; 41: 4428–4433.

38.

Peterson

. The burden of angina pectoris and its complications. Clin Cardiol 2007; 30: I10–I15.

39.

Arora

Chou

Jain

. Effects of enhanced external counterpulsation on health-related quality of life continue 12 months after treatment: A substudy of the multicenter study of enhanced external counterpulsation. J Investig Med 2002; 50: 25–32.

40.

Michaels

Linnemeier

Soran

. Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry (IEPRI)). Am J Cardiol 2004; 93: 461–464.

41.

Soran

Kennard

Kfoury

. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (Report from the International EECP Patient Registry). Am J Cardiol 2006; 95: 17–20.

42.

Cepeda-Valery

Cheong

Lee

. Measuring health related quality of life in coronary heart disease: The importance of feeling well. Int J Cardiol 2011; 149: 4–8.

43.

Dempster

ad Donnelly

. Measuring the health related quality of life of people with ischemic heart disease. Heart 2000; 83: 641–644.

44.

Braith

Conti

Nicholas

. Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: A randomized sham-controlled study. Circulation 2010; 122: 1612–1620.

45.

Pettersson

Bondesson

Cojocaru

. One year follow-up of patients with refractory angina pectoris treated with enhanced external counterpulsation. BMC Cardiovasc Disord 2006; 6: 1–7.